Epicrispr Biotechnologies vs Forlong Biotechnology
Epicrispr Biotechnologies vs Forlong Biotechnology, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Epicrispr Biotechnologies is on 62/100 and Forlong Biotechnology on 42/100.
Where each one leads
Epicrispr Biotechnologies
- our overall score: 62/100 against 42/100
- agent readiness: 39/100 against 21/100
- funding raised: $90.0M against $22.5M
Forlong Biotechnology
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Epicrispr Biotechnologies | Forlong Biotechnology |
|---|---|---|
| What it is | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). | Clinical-stage biotech company developing transformative cytokine therapies. |
| Category | Biotechnology, Therapeutics, Rare Diseases, Epigenetics | Biotechnology, Pharmaceuticals, Healthcare, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | Not published |
| Headquarters | South San Francisco, United States | Shanghai, China |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Epicrispr Biotechnologies | Forlong Biotechnology |
|---|---|---|
| Employees | 51 | Not published |
| Total funding | $90.0M | $22.5M |
| Latest round | Series C | Series Pre-B |
| LinkedIn followers | 7,025 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Epicrispr Biotechnologies | Forlong Biotechnology |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 42/100 |
| Traction | 57/100 | 37/100 |
| Team | 40/100 | Not published |
| Search visibility | 20/100 | 12/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 40/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Epicrispr Biotechnologies | Forlong Biotechnology |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Epicrispr Biotechnologies vs Forlong Biotechnology: common questions
Which is better, Epicrispr Biotechnologies or Forlong Biotechnology?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Epicrispr Biotechnologies and Forlong Biotechnology compare on the numbers?
Epicrispr Biotechnologies leads on our overall score (62/100 against 42/100), agent readiness (39/100 against 21/100), funding raised ($90.0M against $22.5M).
Read the full Epicrispr Biotechnologies review and pricing or the Forlong Biotechnology review and pricing. You can also browse other Epicrispr Biotechnologies alternatives we track.